Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'doxorubicin' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 4450 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ten Hagen, TLM; Seynhaeve, ALB; Van Tiel, ST; Ruiter, DJ; Eggermont, AMM
      Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil (R)) in soft tissue sarcoma-bearing rats

      INTERNATIONAL JOURNAL OF CANCER
    2. Buchholz, TA; Hill, BS; Tucker, SL; Frye, DK; Kuerer, HM; Buzdar, AU; McNeese, MD; Singletary, SE; Ueno, NT; Pusztai, L; Valero, V; Hortobagyi, GN
      Factors predictive of outcome in patients with breast cancer refractory toneoadjuvant chemotherapy

      CANCER JOURNAL
    3. Walczak, RJ; Hines, JV; Strohl, WR; Priestley, ND
      Bioconversion of the anthracycline analogue desacetyladriamycin by recombinant DoxA, a p450-monooxygena from Streptomyces sp strain c5

      ORGANIC LETTERS
    4. Trope, C; Kristensen, GB; Abeler, VM
      Clear-cell and papillary serous cancer: treatment options

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    5. ten Hagen, TLM; Eggermont, AMM; Lejeune, FL
      TNF is here to stay - revisited

      TRENDS IN IMMUNOLOGY
    6. Johnston, SRD; Kaye, S
      Caelyx: treatment for relapsing ovarian cancer

      HOSPITAL MEDICINE
    7. Godwin, A; Hartenstein, M; Muller, AHE; Brocchini, S
      Narrow molecular weight distribution precursors for polymer-drug conjugates

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    8. Dekany, G; Csoka, I; Eros, I
      Interaction between liposomes and neutral polymers; effect of stabilizing on drug release.

      MAGYAR KEMIAI FOLYOIRAT
    9. Zagotto, G; Gatto, B; Moro, S; Sissi, C; Palumbo, M
      Anthracyclines: recent developments in their separation and quantitation

      JOURNAL OF CHROMATOGRAPHY B
    10. Hempel, G; Schulze-Westhoff, P; Flege, S; Boos, J
      Quantification of daunorubicin and daunorubicinol in plasma by capillary electrophoresis

      JOURNAL OF CHROMATOGRAPHY B
    11. Bellott, R; Pouna, P; Robert, J
      Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome

      JOURNAL OF CHROMATOGRAPHY B
    12. Ford, CHJ; Osborne, PO; Mathew, A; Rego, BG
      Affinity purification of novel bispecific antibodies recognising carcinoembryonic antigen and doxorubicin

      JOURNAL OF CHROMATOGRAPHY B
    13. Eliasson, C; Loren, A; Murty, KVGK; Josefson, M; Kall, M; Abrahamsson, J; Abrahamsson, K
      Multivariate evaluation of doxorubicin surface-enhanced Raman spectra

      SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
    14. Kostoryz, EL; Yourtee, DM
      Oxidative mutagenesis of doxorubicin-Fe(III) complex

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    15. Lothstein, L; Israel, M; Sweatman, TW
      Anthracycline drug targeting: cytoplasmic versus nuclear - a fork in the road

      DRUG RESISTANCE UPDATES
    16. Barenholz, Y
      Liposome application: problems and prospects

      CURRENT OPINION IN COLLOID & INTERFACE SCIENCE
    17. Filigheddu, N; Fubini, A; Baldanzi, G; Cutrupi, S; Ghe, C; Catapano, F; Broglio, F; Bosia, A; Papotti, M; Muccioli, G; Ghigo, E; Deghenghi, R; Graziani, A
      Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death

      ENDOCRINE
    18. Harries, M; Kaye, SB
      Recent advances in the treatment of epithelial ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    19. Mitsiades, N; Poulaki, V; Mitsiades, CS; Anderson, KC
      Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors:new tricks from a (not so) old drug

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    20. Wadler, S
      New developments in the treatment of ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    21. Damen, EWP; de Groot, FMH; Scheeren, HW
      Novel anthracycline prodrugs

      EXPERT OPINION ON THERAPEUTIC PATENTS
    22. Lonning, PE; Sorlie, T; Perou, CM; Brown, PO; Botstein, D; Borresen-Dale, AL
      Microarrays in primary breast cancer - lessons from chemotherapy studies

      ENDOCRINE-RELATED CANCER
    23. Orlandi, F; Caraci, P; Mussa, A; Saggiorato, E; Pancani, G; Angeli, A
      Treatment of medullary thyroid carcinoma: an update

      ENDOCRINE-RELATED CANCER
    24. Cuvillier, O; Nava, VE; Murthy, SK; Edsall, LC; Levade, T; Milstien, S; Spiegel, S
      Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells

      CELL DEATH AND DIFFERENTIATION
    25. Bendas, G
      Immunoliposomes - A promising approach to targeting cancer therapy

      BIODRUGS
    26. Chopin, D; Gattegno, B
      Intravesical chemotherapy

      PROGRES EN UROLOGIE
    27. Takeuchi, H; Kojima, H; Yamamoto, H; Kawashima, Y
      Evaluation of the anti-tumour activity of liposomal doxorubicin coated with hydrophilic polymers in tumour-bearing mice

      STP PHARMA SCIENCES
    28. Gravis, G; Mousseau, M; Douillard, JY; Dorval, T; Fabbro, M; Escudier, B; Mignot, L; Viens, P
      Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trial

      EUROPEAN CYTOKINE NETWORK
    29. Zerbi, S; Saruggia, M; Brambilla, L; Lodeville, D; Buccianti, G
      Kaposi's sarcoma in a patient with focal glomerulosclerosis

      JOURNAL OF NEPHROLOGY
    30. Bacci, G; Lari, S
      Current treatment of high grade osteosarcoma of the extremity: Review

      JOURNAL OF CHEMOTHERAPY
    31. Camci, C; Sari, R; Sevinc, A; Buyukberber, S
      Dacarbazine-induced carotid artery and deep venous thrombosis in a patientwith leiomyosarcoma: Case report

      JOURNAL OF CHEMOTHERAPY
    32. Bacci, G; Ferrari, S; Longhi, A; Forni, C; Bertoni, F; Fabbri, N; Zavatta, M; Versari, M
      Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: Long-term results for patients treated according to the rizzoli IOR/OS-3b protocol

      JOURNAL OF CHEMOTHERAPY
    33. Tominaga, T; Sano, M; Nishi, T; Sasaki, M; Yoshida, K; Kimura, M; Takashima, S; Asano, T; Yoshida, M; Fujiwara, J; Danno, M
      Postoperative chemoendocrine therapy for women with node-positive stage IIbreast cancer with combined cyclophosphamide, tamoxifen, and 1-hexylcarbamoyl-5-fluorouracil

      EUROPEAN JOURNAL OF SURGERY
    34. Goodwin, SC; Bittner, CA; Peterson, CL; Wong, G
      Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier

      TOXICOLOGICAL SCIENCES
    35. Casares, S; Stan, AC; Bona, CA; Brumeanu, TD
      Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MI-IC II-peptide chimera

      NATURE BIOTECHNOLOGY
    36. Becherer, A; Vierhapper, H; Potzi, C; Karanikas, G; Kurtaran, A; Schmaljohann, J; Staudenherz, A; Dudczak, R; Kletter, K
      FDG-PET in adrenocortical carcinoma

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    37. Wang, XP; Pudavar, HE; Kapoor, R; Krebs, LJ; Bergey, EJ; Liebow, C; Prasad, PN; Nagy, A; Schally, AV
      Studies on the mechanism of action of a targeted chemotherapeutic drug in living cancer cells by two photon laser scanning microspectrofluorometry

      JOURNAL OF BIOMEDICAL OPTICS
    38. Kim, DW; Andres, ML; Li, J; Kajioka, EH; Miller, GM; Seynhaeve, ALB; Ten Hagen, TLM; Gridley, DS
      Liposome-encapsulated tumor necrosis factor-alpha enhances the effects of radiation against human colon tumor xenografts

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    39. Abraham, EH; Shrivastav, B; Salikhova, AY; Sterling, KM; Johnston, N; Guidotti, G; Scala, S; Litman, T; Chan, KC; Arceci, RJ; Steiglitz, K; Herscher, L; Okunieff, P
      Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes

      BLOOD CELLS MOLECULES AND DISEASES
    40. Herr, HW; Donat, SM; Bajorin, DF
      Bladder cancer, the limits of surgical excision - when/how much?

      UROLOGIC ONCOLOGY
    41. Millikan, R; Baez, L; Banerjee, T; Wade, J; Edwards, K; Winn, R; Smith, TL; Logothetis, C
      Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancer

      UROLOGIC ONCOLOGY
    42. Nejat, RJ; Purohit, R; Goluboff, ET; Petrylak, D; Rubin, MA; Benson, MC
      Cure of undifferentiated small cell carcinoma of the urinary bladder with M-VAC chemotherapy

      UROLOGIC ONCOLOGY
    43. Landau, HJ; Poiesz, BJ; Dube, S; Bogart, JA; Weiner, LB; Souid, AK
      Classic Kaposi's sarcoma associated with human herpesvirus 8 infection in a 13-year-old male: A case report

      CLINICAL CANCER RESEARCH
    44. Harris, LN; Yang, L; Liotcheva, V; Pauli, S; Iglehart, JD; Colvin, OM; Hsieh, TS
      Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy

      CLINICAL CANCER RESEARCH
    45. Seraj, MJ; Thomas, AR; Chin, JL; Theodorescu, D
      Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder

      CLINICAL CANCER RESEARCH
    46. Tetef, ML; Synold, TW; Chow, W; Leong, L; Margolin, K; Morgan, R; Raschko, J; Shibata, S; Somlo, G; Yen, Y; Groshen, S; Johnson, K; Lenz, HJ; Gandara, D; Doroshow, JH
      Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies

      CLINICAL CANCER RESEARCH
    47. Petit, T; Borel, C; Ghnassia, JP; Rodier, JF; Escande, A; Mors, R; Haegele, P
      Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting

      CLINICAL CANCER RESEARCH
    48. Gabizon, AA
      Stealth liposomes and tumor targeting: One step further in the quest for the magic bullet

      CLINICAL CANCER RESEARCH
    49. Harrington, KJ; Mohammadtaghi, S; Uster, PS; Glass, D; Peters, AM; Vile, RG; Stewart, JSW
      Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes

      CLINICAL CANCER RESEARCH
    50. Lyass, O; Hubert, A; Gabizon, AA
      Phase I study of doxil-cisplatin combination chemotherapy in patients withadvanced malignancies

      CLINICAL CANCER RESEARCH
    51. Cocker, HA; Tiffin, N; Pritchard-Jones, K; Pinkerton, CR; Kelland, LR
      In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line

      CLINICAL CANCER RESEARCH
    52. Faivre, S; Raymond, E; Boige, V; Gatineau, M; Buthaut, X; Rixe, O; Bernareggi, A; Camboni, G; Armand, JP
      A phase I and pharmacokinetic study of the novel aza-anthracenedione compound BBR 2778 in patients with advanced solid malignancies

      CLINICAL CANCER RESEARCH
    53. Porea, TJ; Dreyer, ZE; Bricker, JT; Mahoney, DH
      Evaluation of left ventricular function in asymptomatic children about to undergo anthracycline-based chemotherapy for acute leukemia: An outcome study

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    54. Shearer, P; Kapoor, G; Beckwith, JB; Takashima, J; Breslow, N; Green, DM
      Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: A report from the National Wilms Tumor Study Group

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    55. Xu, L; Tang, WH; Huang, CC; Alexander, W; Xiang, LM; Pirollo, KF; Rait, A; Chang, EH
      Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv

      MOLECULAR MEDICINE
    56. El-Missiry, MA; Othman, AI; Amer, MA; El-Aziz, MAA
      Attenuation of the acute adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-mercaptopropionyl) glycine in rats

      FREE RADICAL RESEARCH
    57. Henshaw, RM; Priebat, DA; Perry, DJ; Shmookler, BM; Malawer, MM
      Survival after induction chemotherapy and surgical resection for high-grade soft tissue sarcoma. Is radiation necessary?

      ANNALS OF SURGICAL ONCOLOGY
    58. Kramer, K; Kinter, L; Brockway, BP; Voss, HP; Remie, R; Van Zutphen, BLM
      The use of radiotelemetry in small laboratory animals: Recent advances

      CONTEMPORARY TOPICS IN LABORATORY ANIMAL SCIENCE
    59. Calvo-Romero, JM; Fernandez-Soria-Pantoja, R; Arrebola-Garcia, JD; Gil-Cubero, M
      Ischemic heart disease associated with vincristine and doxorubicin chemotherapy

      ANNALS OF PHARMACOTHERAPY
    60. Hershberger, RE; Ni, HY; Toy, W; Wilson, RA
      Distribution and declines in cardiac allograft radionuclide left ventricular ejection fractions in relation to late mortality

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    61. Nguyen, NP; Sallah, S; Karlsson, U; Vos, P; Ludin, A; Semer, D; Tait, D; Salehpour, M; Jendrasiak, G; Robiou, C
      Prognosis for papillary serous carcinoma of the endometrium after surgicalstaging

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    62. Huang, YC; Hsu, KF; Chou, CY; Dai, YC; Tzeng, CC
      Ovarian fibrosarcoma with long-term survival: A case report

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    63. Balega, J; Ulbright, TM; Look, KY
      Coexistence of metastatic neuroendocrine carcinoma of the uterine cervix with human immunodeficiency virus infection

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    64. Luck, HJ; Du Bois, A; Weber, B; Pfisterer, J; Goupil, A; Kuhn, W; Barats, JC; Blohmer, J; Mousseau, M; Schroder, W; Meier, W; Mobus, V; Richter, B
      The integration of anthracyclines in the treatment of advanced ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    65. Conte, PF; Gadducci, A; Cianci, C
      Second-line treatment and consolidation therapies in advanced ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    66. Sayed-Ahmed, MM; Salman, TM; Gaballah, HE; El-Naga, SAA; Nicolai, R; Calvani, M
      Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy

      PHARMACOLOGICAL RESEARCH
    67. Saad, SY; Najjar, TA; Al-Rikabi, AC
      The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats

      PHARMACOLOGICAL RESEARCH
    68. Fleiner, M; Benzinger, P; Fichert, T; Massing, U
      Studies on protein-liposome coupling using novel thiol-reactive coupling lipids: Influence of spacer length and polarity

      BIOCONJUGATE CHEMISTRY
    69. Guo, X; Szoka, FC
      Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG-diortho ester-lipid conjugate

      BIOCONJUGATE CHEMISTRY
    70. Ranson, MR; Cheeseman, S; White, S; Margison, J
      Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breastcancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    71. Chiara, S; Lionetto, R; Vincenti, M; Bruzzone, M; Nobile, MT; Gadducci, A; Carnino, F; Rosso, R; Conte, P
      Advanced ovarian cancer in the elderly: results of consecutive trials withcisplatin-based chemotherapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    72. Kim-James, HY; Heffernan, MP
      The diagnosis, evaluation, and treatment of cutaneous T-cell lymphoma

      CURRENT PROBLEMS IN DERMATOLOGY-US
    73. Kabanov, AV; Batrakova, EV; Li, S; Alakhov, VY
      Selective energy depletion and sensitization of multiple drug-resistant cancer cells by pluronic block copolymer

      MACROMOLECULAR SYMPOSIA
    74. Berrak, SG; Ewer, MS; Jaffe, N; Pearson, P; Ried, K; Zietz, HA; Benjamin, RS
      Doxorubicin cardiotoxicity in children: Reduced incidence of cardiac dysfunction associated with continuous-infusion schedules

      ONCOLOGY REPORTS
    75. Beech, DJ; Parekh, N; Pang, Y
      Insulin-like growth factor-I receptor antagonism results in increased cytotoxicity of breast cancer cells to doxorubicin and taxol

      ONCOLOGY REPORTS
    76. Bobbio-Pallavicini, E; Tacconi, F; Porta, C; Brambilla, G; Mainardi, E; Bianchessi, C; Moroni, M
      Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: A phase-II study

      ONCOLOGY REPORTS
    77. Shimose, S; Sugita, T; Nitta, Y; Kubo, T; Ikuta, Y; Murakami, T
      Effect of thermosensitive liposomal doxorubicin with hyperthermia on primary tumor and lung metastases in hamster osteosarcoma

      INTERNATIONAL JOURNAL OF ONCOLOGY
    78. Zagozdzon, R; Golab, J
      Immunomodulation by anticancer chemotherapy: More is not always better (review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    79. Kubo, T; Sugita, T; Shimose, S; Nitta, Y; Ikuta, Y; Murakami, T
      Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters

      INTERNATIONAL JOURNAL OF ONCOLOGY
    80. Dai, CL; Xia, ZL; Kume, M; Yamamoto, Y; Yamagami, K; Ozaki, N; Yamaoka, Y
      Heat shock protein 72 normothermic ischemia, and the impact of congested portal blood reperfusion on rat liver

      WORLD JOURNAL OF GASTROENTEROLOGY
    81. Heine, D; Muller, R; Brusselbach, S
      Cell surface display of a lysosomal enzyme for extracellular gene-directedenzyme prodrug therapy

      GENE THERAPY
    82. Hakimelahi, GH; Ly, TW; Yu, SF; Zakerinia, M; Khalafi-Nezhad, A; Soltani, MN; Gorgani, MN; Chadegani, AR; Moosavi-Movahedi, AA
      Design and synthesis of a cephalosporin-retinoic acid prodrug activated bya monoclonal antibody-beta-lactamase conjugate

      BIOORGANIC & MEDICINAL CHEMISTRY
    83. Batchelor, D
      Hair and cancer chemotherapy: consequences and nursing care - a literaturestudy

      EUROPEAN JOURNAL OF CANCER CARE
    84. Davidson, NE; Wolff, AC
      The use of anthracyclines and taxanes for adjuvant therapy of breast cancer

      BREAST
    85. Lohrisch, C; Di Leo, A; Piccart, MJ
      Optimal adjuvant cytotoxic therapy for breast cancer

      BREAST
    86. Swenson, CE; Perkins, WR; Roberts, P; Janoff, AS
      Liposome technology and the development of Myocet (TM) (liposomal doxorubicin citrate)

      BREAST
    87. Verrill, M
      Anthracyclines in breast cancer: therapy and issues of toxicity

      BREAST
    88. Batist, G
      Improving the therapeutic index when using Myocet (TM) in the treatment ofmetastatic breast cancer

      BREAST
    89. Schmid, P; Possinger, K
      Liposomal anthracyclines for improved cardiac tolerability

      BREAST
    90. Breitbart, E; Lomnitski, L; Nyska, A; Malik, Z; Bergman, M; Sofer, Y; Haseman, JK; Grossman, S
      Effects of water-soluble antioxidant from spinach, NAO, on doxorubicin-induced heart injury

      HUMAN & EXPERIMENTAL TOXICOLOGY
    91. Gomes, ML; de Mattos, DMM; Freitas, RD; Bezerra, RJAC; Bernardo-Filho, M
      Study of the toxicological effect of mitomycin C in mice: alteration on the biodistribution of radiopharmaceuticals used for renal evaluations

      HUMAN & EXPERIMENTAL TOXICOLOGY
    92. Namer, M; Soler-Michel, P; Turpin, F; Chinet-Charrot, P; de Gislain, C; Pouillart, P; Delozier, T; Luporsi, E; Etienne, PL; Schraub, S; Eymard, JC; Serin, D; Ganem, G; Calais, G; Maillart, P; Colin, P; Trillet-Lenoir, V; Prevost, G; Tigaud, D; Clavere, P; Marti, P; Romieu, C; Wendling, JL
      Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

      EUROPEAN JOURNAL OF CANCER
    93. Judson, I; Radford, JA; Harris, M; Blay, JY; van Hoesel, Q; le Cesne, A; van Oosterom, AT; Clemons, MJ; Kamby, C; Hermans, C; Whittaker, J; di Paola, ED; Verweij, J; Nielsen, S
      Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL (R)/CAELYX (R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

      EUROPEAN JOURNAL OF CANCER
    94. Hengge, UR; Esser, S; Rudel, HP; Goos, M
      Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin

      EUROPEAN JOURNAL OF CANCER
    95. Kiaris, H; Schally, AV; Nagy, A; Szepeshazi, K; Hebert, F; Halmos, G
      A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice

      EUROPEAN JOURNAL OF CANCER
    96. Menendez, JA; Barbacid, MD; Montero, S; Sevilla, E; Escrich, E; Solanas, M; Cortes-Funes, H; Colomer, R
      Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells

      EUROPEAN JOURNAL OF CANCER
    97. Gonzalez-Paz, O; Polizzi, D; De Cesare, M; Zunino, F; Bigioni, M; Maggi, CA; Manzini, S; Pratesi, G
      Tissue distribution, antitumour activity and in vivo apoptosis induction by MEN10755 in nude mice

      EUROPEAN JOURNAL OF CANCER
    98. Harrington, KJ; Lewanski, C; Northcote, AD; Whittaker, J; Peters, AM; Vile, RG; Stewart, JSW
      Phase II study of pegylated liposomal doxorubicin (Caelyx (TM)) as induction chemotherapy for patients with squamous cell cancer of the head and neck

      EUROPEAN JOURNAL OF CANCER
    99. Bacci, G; Briccoli, A; Ferrari, S; Longhi, A; Mercuri, M; Capanna, R; Donati, D; Lari, S; Forni, C; DePaolis, M
      Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol

      EUROPEAN JOURNAL OF CANCER
    100. Caroli-Bosc, FX; Van Laethem, JL; Michel, P; Gay, F; Hendlisz, A; Forget, F; Bleiberg, H
      A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomas

      EUROPEAN JOURNAL OF CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 02:26:20